ESICM 2024 Research Awards
The submission platform for the ESICM 2024 Awards campaign is now closed.
ESICM offers direct funding to researchers in the field of Intensive Care Medicine. Intensivists working in all areas of the discipline are invited to apply by submitting their proposed research projects.
14 grants for a total value of €295,000 are available in 2024 including two industry-funded awards: the ESICM Jordi Mancebo Fisher&Paykel Award and the ESICM Fresenius Kabi Award.
How to apply
For information relating to the application process and conditions please read the ESICM 2024 Awards Programme Overview. Candidates are advised to read this document carefully before submitting their application. Any application that does not comply with the guidelines will unfortunately be rejected. Read more here on the short application platform.
Except the members of the ESICM Research Committee and Executive Committee who do not qualify, the Society accepts applications from anyone who is a member.
There are two stages to the application process:
- First, candidates must submit a short application. This is an outline of the aims and methodology of the proposed research project and must include an estimated budget and timeline. All short applications are reviewed by the Research Committee.
- Those selected will be contacted in April and asked to submit a full application. This is a full project description with details regarding feasibility, research design and methodology.
All full applications are reviewed by a minimum of two independent expert assessors. These assessments are thoroughly discussed at the Awards Jury Meeting by members of the Research Committee. The Jury meeting takes place around the end of the Summer.
We wish to draw your attention to the following conditions of entry in particular:
- ESICM wishes to encourage research carried out across several countries.
- After a year, awardees will be requested to provide research@esicm.org with a progress report.
- Successful applicants shall be required to submit their primary paper to ICM.
Please note that the most suitable award category for each application is decided by the Jury and not chosen by the applicant.
Please write to research [ @ ] esicm.org for any questions
Available Research Awards
Through its research programme ESICM provides an impetus to research activities among the Society’s members. Facilitating and promoting research is one of the principle objectives of the Society.
The range of awards offered by ESICM covers the entire spectrum of critical care, including but not limited to basic, translational and clinical research, patient and family partnership, digital health and multi-disciplinary care.
ESICM Basic Science Award
The Basic Science Award has long supported research in this area. This category covers all areas of basic research from basic cellular and molecular physiology, cell biology, molecular biology and genetics to animal physiology. The Basic Science Award is a sum of €20,000 and is fully funded by ESICM.
2023 Awardee: Marta Camprubí Rimblas “Effects of hypercapnia and pneumonia-causing bacteria in a lung-on-a-chip model (HyPChip)”.
ESICM Fundamental Research Award
Groundbreaking intensive care treatments are so often discovered through fundamental research. The new Fundamental Research Award has been created to encourage exploratory research across the broad field of intensive care medicine. The Fundamental Research Award is a sum of €20,000 and is fully funded by ESICM.
2023 Awardee: Aleksandra Larina “Effects of steroids on ventilation/perfusion match assessed by dual energy computed tomography in pre-clinical models of intrapulmonary and extrapulmonary ARDS”.
Professor Burkhard Lachmann Award
Projects that are pre-selected for the Basic Science Award may go forward for consideration for the Professor Burkhard Lachmann award with the agreement of the candidate. The Professor Burkhard Lachmann Award is a grant of €5,000 and is fully funded by the International Foundation for Clinically Oriented Research (IFCOR).
2023 Awardee: Patrick Collins “Accelerating liberation from veno-venous ECMO: a randomised crossover physiological study”.
ESICM Family Partnership Award
Any research proposal that centres on the needs, priorities and expectations of patients and their carers will qualify for this award. Other elements such as patient-carer interactions and long-term outcomes in ICU survivors are relevant. We encourage N&AHP members to apply. The Family Partnership Award is a sum of €20,000 and is fully funded by ESICM.
2023 Awardee: Susannah Leaver “The VIP-3 study: Decision-making in the older ICU Patient: How are Family Meetings implemented across diverse European Cultures?”.
ESICM Global ICU Award
The Global ICU Award is intended for projects conducted in a Low & Middle Income Country as defined by the 2021 Low & Middle Income Countries list compiled by the World Bank and approved by the WHO. The projects should have an educational element focusing on improving patient care. The Global ICU Award is a sum of €20,000 and is fully funded by ESICM.
2023 Awardee: Bharath Kumar Tirupakuzhi Vijayaraghavan “Epidemiology and outcomes of Severe Dengue in Lower-Middle Income Countries in South and Southeast Asia”.
ESICM Established Investigator Award
The Established Investigator Award supports investigators who have already established their independent research programme in the field of intensive care and emergency medicine, and who can demonstrate a commitment to training of young colleagues. The proposal may rely on approaches ranging from basic cellular responses to outcome research, and may include clinical applications as well as translational science. The Established Investigator Award is a sum of €20,000 which is fully funded by ESICM.
2023 Awardee: Lene Russel “Diagnosis and outcome of patients with disseminated intravascular coagulation (DIC) in the ICU”.
ESICM Young Investigator Award
ESICM wishes to invest in young, talented scientists who have the potential to become outstanding independent investigators. ESICM members aged 40 or younger at the time of applying are eligible for the Young Investigator Award. Research proposals may focus on any aspect of intensive care medicine. The Young Investigator Award is a grant of €20,000 and is fully funded by ESICM.
2023 Awardee: Charles Piercy “Characterization of Endothelial cells in vasoplegia and sepsis”.
NEXT Start-Up Grant
The NEXT Start-Up Grant supports the professional development of young and talented researchers with a solid background in research. Members under or equal to 37 years will qualify for this award. The NEXT Start-Up Grant offers €25,000 per year for up to two years. This grant is fully funded by ESICM.
2023 Awardee: Gennaro De Pascale “HAP/VAP Diagnosis in Critically ill Septic Patients using a Multiplex PCR Assay: A Multicenter Randomized Trial. The Lightning study”.
ESICM Clinical Research Award
The Clinical Research Award is for projects carried out in a clinical environment. Some aspects of the proposal may involve collaboration with research laboratories. Applications that lack a clinical component will not be considered. Proposals may be based on approaches ranging from physiology, diagnostic procedures, therapeutic interventions, to epidemiologic studies and evaluation of practices. The Clinical Research Award is a grant of €20,000 and is fully funded by ESICM.
2023 Awardee: Rory McDonald “The effect of vasopressor therapy on renal perfusion in patients with septic shock – the REPERFUSE study”.
ESICM Translational Research Award
The interdisciplinary field of translational science identifies and supports the adoption of best medical and health practices. By creating the translational research award ESICM puts a spotlight on this area. The Translational Research Award is a grant of €20,000 and is fully funded by ESICM.
2023 Awardee: Anna Kleyman “24-OH-hydroxycholesterol as a biomarker for sepsis-induced brain dysfunction (SIBD)”.
ESICM Levi-Montalcini Biomedical Sciences Award
ESICM is committed to equal opportunity in science and has established this award to encourage women to join the research community. ESICM looks forward to receiving applications from female scientists and physicians. The Levi-Montalcini Biomedical Sciences Award is a grant of €20,000 which is fully funded by ESICM.
2023 Awardee: Aina Areny-Balagueró “Synthetic nanocapsules as innovative treatment for sepsis (SPRINT-4-SEPSIS)”.
ESICM Multi-Disciplinary Care Award
The Multi-Disciplinary Care Award has been created to support healthcare professionals who have identified areas of intensive care treatment where research is required and who have perhaps never before considered entering the field of research. Applications are welcome from allied healthcare professionals of all disciplines relating to intensive care. The Multi-Disciplinary Care is a grant of €20,000 which is fully funded by ESICM.
2023 Awardee: Jan Fierens “Impact of antimicrobial treatment strategies on emergence of resistance (BALANCE)”.
ESICM – Jordi Mancebo – Fisher&Paykel Healthcare SAS Award
The call for ESICM 2023 Jordi Mancebo Fisher&Paykel Award applications is now open! Projects must pertain to physiological or clinical outcomes of less invasive respiratory support in acute respiratory failure. The ESICM 2023 Jordi Mancebo Fisher&Paykel Healthcare SAS award is €20,000 and is fully funded by Fisher&Paykel Healthcare. The proposals should include at least one European country contributing to the design and/or conduct of the project.
2023 Awardee: Oriol Roca “Assessing the effect on lung aeration for flow individualization in patients treated with high flow nasal cannula: a physiological study – The iFlow study”.
ESICM – Fresenius Kabi Clinical Nutrition Award
The project focus is clinical nutrition.
The ESICM Fresenius Kabi Clinical Nutrition Award is €20,000 and is fully funded by Fresenius Kabi. The proposals should include at least one country contributing to the design and / or conduct of the project.
2023 Awardee: Arthur van Zanten “Prospective, multicenter study to validate the GastroIntestinal Dysfunction Score (GIDS) and describe prevalence, outcomes, and management of phosphate disorders in intensive care patients”.
